TYP 0.00% 4.1¢ tryptamine therapeutics limited

Ann: Shareholder Update, page-24

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 37,911 Posts.
    lightbulb Created with Sketch. 828
    59,810,430 Fully Paid Ordinary Shares
    35,661,570 Fully Paid Ordinary Shares (escrowed 24 months from Official Quotation)
    https://www.asx.com.au/asxpdf/20190916/pdf/448k278lz5kypq.pdf

    Exopharm Limited was admitted to the Official List of ASX Limited on 14 December 2018.

    35,661,570 shares to be released from escrow on 14 December 2020.
    Last edited by ddzx: 13/02/20
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.000(0.00%)
Mkt cap ! $44.65M
Open High Low Value Volume
4.1¢ 4.2¢ 3.9¢ $194.6K 4.842M

Buyers (Bids)

No. Vol. Price($)
3 225000 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 640219 3
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.